Pregabalin 75 mg, Methylcobalamin 750 mcg. Alpha Lipoic Acid 100 mg, Pyridoxine Hydrochloride 3 mg + Folic Acid 1.5 mg Capsules (Uncoated (SR) Cap)

Pregabalin 75 mg, Methylcobalamin 750 mcg. Alpha Lipoic Acid 100 mg, Pyridoxine Hydrochloride 3 mg + Folic Acid 1.5 mg Capsules (Uncoated (SR) Cap) is a capsule formulated with Pregabalin 75 mg, Methylcobalamin 750 mcg. Alpha Lipoic Acid 100 mg, Pyridoxine Hydrochloride 3 mg + Folic Acid 1.5 mg ( (SR) Cap). The listed active ingredient profile is Pregabalin; Methylcobalamin . Alpha Lipoic Acid; Pyridoxine Hydrochloride; Folic Acid Cap), placing the product in the neuropathic pain / neuro-nutritional category. The formulation contains neuropathic-pain and/or neuro-nutritional components used in selected nerve-related conditions under clinician guidance. The source indicates sustained release; uncoated characteristics, which should be retained exactly because release technology can affect administration and product performance. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.